Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
Dupilumab is a monoclonal antibody against the a subunit of the receptor for interleukin 4 and interleukin 13. It is the first biological drug registered in the world for the treatment of atopic dermatitis. Dupilumab turned out to be a milestone in the treatment of atopic dermatitis and an alternati...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Girji |
| Almmustuhtton: |
Termedia Publishing House,
2023-03-01T00:00:00Z.
|
| Fáttát: | |
| Liŋkkat: | Connect to this object online. |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_119edbdabd0d46a2b9a0d19a2523f7c6 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Mikołaj Cichoń |e author |
| 700 | 1 | 0 | |a Jowita Sroka-Tomaszewska |e author |
| 700 | 1 | 0 | |a Magdalena Trzeciak |e author |
| 245 | 0 | 0 | |a Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis |
| 260 | |b Termedia Publishing House, |c 2023-03-01T00:00:00Z. | ||
| 500 | |a 0033-2526 | ||
| 500 | |a 2084-9893 | ||
| 500 | |a 10.5114/dr.2022.125683 | ||
| 520 | |a Dupilumab is a monoclonal antibody against the a subunit of the receptor for interleukin 4 and interleukin 13. It is the first biological drug registered in the world for the treatment of atopic dermatitis. Dupilumab turned out to be a milestone in the treatment of atopic dermatitis and an alternative to standard immunosuppressive drugs. In numerous multicenter studies, including real-life studies, it has been proven that dupilumab brings a significant improvement in subjective and objective clinical symptoms in atopic dermatitis. Conjunctivitis is one of the side effects of dupilumab treatment. It is estimated that it affects about 14% of patients with atopic dermatitis. The mechanisms leading to it are not yet fully understood. | ||
| 546 | |a EN | ||
| 546 | |a PL | ||
| 690 | |a atopic dermatitis | ||
| 690 | |a dupilumab | ||
| 690 | |a conjunctivitis | ||
| 690 | |a Medicine | ||
| 690 | |a R | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Przegląd Dermatologiczny, Vol 109, Iss 5, Pp 344-351 (2023) | |
| 787 | 0 | |n https://www.termedia.pl/Conjunctivitis-as-a-common-adverse-effect-of-dupilumab-r-nin-atopic-dermatitis,56,50272,1,1.html | |
| 787 | 0 | |n https://doaj.org/toc/0033-2526 | |
| 787 | 0 | |n https://doaj.org/toc/2084-9893 | |
| 856 | 4 | 1 | |u https://doaj.org/article/119edbdabd0d46a2b9a0d19a2523f7c6 |z Connect to this object online. |